CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases (CARBON): study protocol for a phase IB/IIA randomised controlled trial

Autor: Rob Coleman, Janet Brown, Emma Rathbone, Louise Flanagan, Amber Reid, Jessica Kendall, Sacha Howell, Chris Twelves, Carlo Palmieri, Anjana Anand, Iain MacPherson, Sarah Brown

Publikováno v: Trials, Vol 21, Iss 1, Pp 1-10 (2020)

Abstract Background A substantial proportion of breast cancer patients develop metastatic disease, with over 450,000 deaths globally per year. Bone is the most common first site of metastatic disease accounting for 40% of all first recurrence and 70%

Externí odkaz: https://doaj.org/article/f23455173b0d42049b53d3ddcd09b49b

2022-RA-1505-ESGO Ovarian cancer retrospective European (O’CaRE) observational study: analysis of first-line (1L) outcomes in patients with ovarian cancer (OC) stratified by number of risk factors for progression

Autor: Jonathan Krell, Thumulurua K Madhuri, Danielle Shaw, John McGrane, Anjana Anand, Andreas Hartkopf, Ana Herrero, Cheng Yeoh, Maria Masvidal, Jean-David Fumet, Gunther Rogmans, Francesco Raspagliesi, Celine Gavoille, Whitney York, Jeanne M Schilder, Barbara Mascialino, Eleanor McDermott, Linda Kalilani, Lars Hanker

Publikováno v: Ovarian cancer.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a3afc0c807eca7c0094aac918ced4c8b
https://doi.org/10.1136/ijgc-2022-esgo.732

A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in high-grade uterine sarcoma after stabilization or response to doxorubicin ± ifosfamide following surgery or in metastatic first line treatment (EORTC62113)

Autor: Antonio Casado, Helen Hatcher, Manon Huizing, Dan Stark, Isabelle Ray-Coquard, Nick Reed, Sarah Pratap, Barbara Hermes, Beatrice Seddon, Nicolas Isambert, Lars H. Lindner, Claudia Valverde, Paolo G. Casali, Anjana Anand, Robin L. Jones, Corneel Coens, Anne Floquet, Annekke Westermann, Emmanuelle Bompas

Publikováno v: International journal of gynecological cancer, 30(10), 1633-1637. Wolters Kluwer Health
International journal of gynecological cancer

Funder: European Organisation for Research and Treatment of Cancer; FundRef: http://dx.doi.org/10.13039/501100004897
Funder: Ligue Nationale de Lutte contre le Cancer (France)
BACKGROUND: Uterine sarcomas are a group of rare tumors that inc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::381dacf9efd4216177c219cf4817d047
https://doi.org/10.1136/ijgc-2020-001519

An Improved Dehazing and De-raining Technique for Haze and Rain Streaks Removal

Autor: L. Nitha, Aparna Suresh, P. R. Meera, Anjana Anand

Publikováno v: Smart Innovation, Systems and Technologies ISBN: 9789811636745

De-raining and dehazing is a challenging problem. To overcome the challenge, this research work develops a novel de-raining and dehazing technique with a combination of dark channel prior technique for dehazing and L0 gradient minimization for de-rai

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e36e458774e477a570fec0c45b603398
https://doi.org/10.1007/978-981-16-3675-2_45

Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial

Autor: Carien L. Creutzberg, Petronella B. Ottevanger, Annamaria Ferrero, Luis Souhami, Pearly Khaw, GH Westerveld, Diane Provencher, Gillian Thomas, Jan Pyman, V. Do, Annerie Slot, C Davidson, G. Wilson, Stephanie M. de Boer, Peter Hoskin, C M McLachlin, Michael A. Quinn, Deborah Gregory, Remi A. Nout, Hans W. Nijman, J.J. Jobsen, Tanja C. Stam, Vincent T.H.B.M. Smit, K Whitmarsh, Paul Bessette, Roy F.P.M. Kruitwagen, W Taylor, Dionyssios Katsaros, Chantal Hanzen, Henry C Kitchener, M McCormack, Prafull Ghatage, Dominique Berton-Rigaud, J.W.M. Mens, Melanie E Powell, Elisabeth Pras, Jonathan A. Ledermann, Karen W Verhoeven-Adema, Harmen Hollema, Andrea Lissoni, Linda Mileshkin, Anjana Anand, Amanda Feeney, Sergio Gribaudo, Marie-Helene Baron, R Allerton, Hein Putter, Colin D. Johnson, P. Symonds, Ina M. Jürgenliemk-Schulz, Romerai D'Amico, Ilka Kolodziej, M Adusumalli, Naveena Singh, G Artioli, An Snyers, R Wade, Christine Haie-Meder, Roldano Fossati, Nicole Tubiana-Mathieu, Anthony Fyles, Silvestro Carinelli, Anne Capp, Alexandra J. Stewart, Kaj De Winter, B. van Triest, L.C.H.W. Lutgens, Susan Brooks, E. Van der Steen-Banasik, Pierre Duvillard, Pvc Rittenberg, Alessandro Colombo

Publikováno v: Lancet Oncology, 20, 1273-1285
Lancet oncology, 20(9), 1273-1285. Elsevier Science
The Lancet Oncology, 20(9), 1273-1285
PORTEC study group 2019, ' Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3) : patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial ', The Lancet Oncology, vol. 20, no. 9, pp. 1273-1285 . https://doi.org/10.1016/S1470-2045(19)30395-X
The Lancet Oncology
Lancet Oncology, 20(9), 1273-1285. ELSEVIER SCIENCE INC
Lancet Oncology, 20, 9, pp. 1273-1285

BACKGROUND:The PORTEC-3 trial investigated the benefit of combined adjuvant chemotherapy and radiotherapy versus pelvic radiotherapy alone for women with high-risk endometrial cancer. We updated the analysis to investigate patterns of recurrence and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce8413d15fc6d6dd5eb177cabf60ffef
https://hdl.handle.net/2066/208651